FRM
MEDP icon

Fox Run Management’s Medpace MEDP Stock Holding History

Fox Run Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
+1,009
New +$466K 0.09% 449
2024
Q3 		– Sell
-497
Closed -$205K – 986
2024
Q2 		$205K Buy
+497
New +$197K 0.04% 671
2024
Q1 		– Sell
-2,148
Closed -$658K – 954
2023
Q4 		$658K Buy
+2,148
New +$580K 0.17% 204
2023
Q3 		– Sell
-2,273
Closed -$546K – 873
2023
Q2 		$546K Buy
+2,273
New +$472K 0.15% 256

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fox Run Management's MEDP Position: Q2 2026 in Review

Fox Run Management opened a new position in Medpace (MEDP) in Q2 2026: 1,009 shares worth $534K. The stake represents 0.09% of the portfolio and ranks #449 among its holdings. This is a return to the name: Fox Run Management previously reported a position in MEDP as recently as Q2 2024.

Fox Run Management first reported a position in MEDP in Q2 2023 and has held it in 4 quarters since. The position peaked at $658K in Q4 2023. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Fox Run Management held 1,009 shares of Medpace worth $534K as of Q2 2026.
  • Medpace was a new Fox Run Management position in Q2 2026.
  • Medpace made up 0.09% of Fox Run Management's portfolio in Q2 2026, its #449 holding.
  • Fox Run Management first reported a position in Medpace in Q2 2023 and has held it in 4 quarters since.
  • Fox Run Management's Medpace position peaked at $658K in Q4 2023.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.